FrancophonIA/ELRC3.0 huggingface dataset:
English: It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotics.
Lithuanian: Tik vienos klasės antibiotikų naudojimas gali sukelti atsparumo atsiradimą bakterijų populiacijoje. Būtų tikslingiausia fluorochinolonus rezervuoti tik tų infekcijų atvejais, kai buvo neefektyvus arba manoma, kad gali būti neefektyvus gydymas kitų klasių antibiotikais.
English: The reproductive safety of the veterinary medicinal product has only been evaluated in laboratory animals, the use of difloxacin in pregnant or lactating bitches or male stud dogs is therefore not recommended.
Lithuanian: Naudojimas vaikingoms patelėms, laktacijos ar kiaušinių dėjimo metu Nerekomenduotina difloksacino naudoti šuningoms kalėms ir laktacijos metu arba veisiamiems šunims (patinams), nes veterinarinio vaisto saugumas reprodukcinėms funkcijoms buvo tirtas tik laboratoriniams gyvūnams.
English: Shelf life of the veterinary medicinal product as packaged for sale: 2 years
Lithuanian: Veterinarinio vaisto tinkamumo laikas, nepažeidus originalios pakuotės, - 2 metai.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/97/003/004 - 10 tablets EU/2/97/003/005 - 20 tablets EU/2/97/003/006 - 100 tablets
Lithuanian: REGISTRACIJOS NUMERIS (-IAI) EU/2/97/003/004 - 10 tablečių EU/2/97/003/005 - 20 tablečių EU/2/97/003/006 - 100 tablečių 17.
English: 8 OJ No. L 143 of 26.06.95
Lithuanian: L 143 26.06.
English: EXP {month/year}
Lithuanian: TINKAMUMO LAIKAS Tinka iki {mėnuo/metai}
English: PACKAGE LEAFLET FOR: Dicural 50 mg/ml solution for injection for cattle and dogs
Lithuanian: INFORMACINIS LAPELIS Dicural 50 mg/ml, injekcinis tirpalas galvijams ir šunims
English: MARKETING AUTHORISATION NUMBER(S) EU/2/97/003/007 - 10 tablets EU/2/97/003/008 - 20 tablets EU/2/97/003/009 - 100 tablets
Lithuanian: EU/2/97/003/007 - 10 tablečių EU/2/97/003/008 - 20 tablečių EU/2/97/003/009 - 100 tablečių
English: Dicural 50 mg difloxacin (as hydrochloride)
Lithuanian: Dicural 50 mg difloksacino (hidrochlorido)
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 100 mg coated tablets for dogs
Lithuanian: Dicural 100 mg, dengtos tabletės šunims
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 50 mg/ml solution for injection for cattle
Lithuanian: VETERINARINIO VAISTO PAVADINIMAS Dicural 50 mg/ml injekcinis tirpalas galvijams ir šunims
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 15 mg coated tablets for dogs
Lithuanian: Dicural 15 mg, dengtos tabletės šunims
English: DATE ON WHICH THE PACKAGE LEAFLET WAS LAST REVISED
Lithuanian: INFORMACINIO LAPELIO PASKUTINIOJO APROBAVIMO DATA
English: [Not required on the immediate label] Dispose of waste material in accordance with local requirements.
Lithuanian: SPECIALIOS NESUNAUDOTO VETERINARINIO VAISTO AR ATLIEKŲ NAIKINIMO NUOSTATOS, JEI BŪTINA [Not requested on the immediate label] Nesunaudoto veterinarinio vaisto likučiai ar su juo susijusios atliekos turi būti sunaikintos pagal šalies reikalavimus.
English: Coated tablets
Lithuanian: 100 tablečių
English: Benzyl alcohol Propylene glycol Arginine
Lithuanian: Etanolis, benzilo alkoholis, propilenglikolis, argininas, injekcinis vanduo.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 50 mg coated tablets for dogs
Lithuanian: Dicural 50 mg, dengtos tabletės šunims
English: ANNEX II A. MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY AND USE C. CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO SAFE AND EFFECTIVE USE D. STATEMENT OF THE MRLs
Lithuanian: REGISTRAVIMO LIUDIJIME NURODYTI TIEKIMO IR NAUDOJIMO SĄLYGOS AR APRIBOJIMAI
English: Overdosage may also give rise to oedema and swelling in the knee joints.
Lithuanian: Šios rūšies gyvūnams perdozavimas taip pat gali sukelti edemą ir kelių sąnarių tynimą.
English: Cattle: Meat and offal: 46 days
Lithuanian: Galvijai Galvijienai ir subproduktams - 46 paros.
English: B. CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION
Lithuanian: REGISTRAVIMO SĄLYGOS, ĮSKAITANT APRIBOJIMUS TIEKTI IR NAUDOTI
English: STATEMENT OF ACTIVE AND OTHER SUBSTANCES Difloxacin (as hydrochloride) 50 mg
Lithuanian: VEIKLIOJI IR KITOS MEDŽIAGOS Difloksacinas (hidrochloridas) 50 mg/ml, benzilo alkoholis
English: The recommended dose is 2.5 mg difloxacin/kg bodyweight/day for 3 days (that is, 5ml/100 kg bodyweight/day).
Lithuanian: Po oda reikia švirkšti 2,5 mg difloksacino 1 kg kūno svorio per dieną 3 dienas (t. y., 5 ml preparato 100 kg kūno svorio). Jei praėjus 3 dienoms nėra pakankamo pagerėjimo, gydyti galima dar 2 dienas.
English: Heavy reliance on a single class of antibiotics may result in the induction of resistance in a bacterial population.
Lithuanian: Specialios naudojimo atsargumo priemonės Specialios atsargumo priemonės, naudojant vaistą gyvūnams Tik vienos klasės antibiotikų naudojimas gali sukelti atsparumo atsiradimą bakterijų populiacijoje. Būtų tikslingiausia fluorochinolonus rezervuoti tik tų infekcijų atvejais, kai buvo neefektyvus arba manoma, kad gali būti neefektyvus gydymas kitų klasių antibiotikais.
English: Shelf life of the veterinary medicinal product as packaged for sale: 2 years 6.4 Special precautions for storage
Lithuanian: Veterinarinio vaisto tinkamumo laikas, nepažeidus originalios pakuotės - 2 metai.
English: Overdose
Lithuanian: Perdozavimas
English: Skilarence is available as tablets (30 and 120 mg).
Lithuanian: Gaminamos Skilarence tabletės (30 ir 120 mg) forma.
English: The full EPAR for Skilarence can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Lithuanian: Išsamų Skilarence EPAR rasite agentūros interneto svetainėje adresu: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Other information about Skilarence
Lithuanian: Kita informacija apie Skilarence
English: Skilarence dimethyl fumarate
Lithuanian: Skilarence dimetilfumaratas
English: What is Skilarence and what is it used for?
Lithuanian: Kas yra Skilarence ir kam jis vartojamas?
English: Most side effects are mild or moderate.
Lithuanian: Dauguma šalutinių reiškinių yra lengvi arba vidutinio sunkumo.
English: What measures are being taken to ensure the safe and effective use of Skilarence?
Lithuanian: Kokios priemonės taikomos siekiant užtikrinti saugų ir veiksmingą
English: It is not intended to provide practical advice on how to use Skilarence.
Lithuanian: Šiame dokumente nepateikta praktinės informacijos apie tai, kaip vartoti Skilarence.
English: The main measure of effectiveness was the proportion of patients who achieved a 75% reduction in their score for disease severity.
Lithuanian: Pagrindinis veiksmingumo rodiklis buvo pacientų, kurių ligos sunkumo vertinimas balais sumažėjo 75 proc., dalis.
English: What benefits of Skilarence have been shown in studies?
Lithuanian: Kokia Skilarence nauda nustatyta tyrimuose?
English: The CHMP considered that the main study has shown Skilarence's short-term effectiveness, and published studies with similar medicines show that the effectiveness is maintained with continued use.
Lithuanian: CHMP laikėsi nuomonės, kad pagrindiniu tyrimu buvo įrodytas Skilarence trumpalaikis veiksmingumas, o paskelbti tyrimai su panašiais vaistais rodo, kad, toliau vartojant tokius vaistus, jie išlieka veiksmingi.
English: The starting dose is 30 mg once a day and the dose is increased every week according to the schedule shown in the package leaflet until the psoriasis starts improving or until the patient is taking the maximum dose of 240 mg three times a day.
Lithuanian: Pradinė dozė yra 30 mg kartą per parą; kas savaitę ši dozė didinama pagal pakuotės lapelyje nurodytą grafiką, kol psoriazės būklė pradeda lengvėti arba kol pacientas pradeda vartoti didžiausią 240 mg tris kartus per parą dozę.
English: Why is Skilarence approved?
Lithuanian: Kodėl Skilarence buvo patvirtintas?
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Skilarence's benefits are greater than its risks and recommended that it be approved for use in the EU.
Lithuanian: Agentūros Žmonėms skirtų vaistinių preparatų komitetas (CHMP) nusprendė, kad Skilarence nauda yra didesnė už jo keliamą riziką, ir rekomendavo leisti vartoti šį vaistą ES.
English: The company that markets Skilarence will supply educational materials to healthcare professionals about the risk of serious infections, including PML, and how to minimise this risk.
Lithuanian: Skilarence prekiaujanti bendrovė aprūpins sveikatos priežiūros specialistus šviečiamąja medžiaga apie rimtųsunkių infekcijų, įskaitant PDL, pavojų ir apie tai, kaip sumažinti šią riziką.
English: Tablets should be swallowed whole during or immediately after a meal.
Lithuanian: Tabletę reikia nuryti visą, valgant arba vos tik pavalgius.
English: Because Skilarence reduces the activity of the immune system, there is a risk of serious infections, including progressive multifocal leukoencephalopathy (PML, a brain infection), but the risk can be minimised by regular tests for white blood cell counts and stopping treatment if necessary.
Lithuanian: Kadangi Skilarence slopina imuninę sistemą, kyla sunkių infekcijų, įskaitant progresuojančią daugiažidininę leukoencefalopatiją (PDL, galvos smegenų infekciją), pavojus, bet šią riziką galima sumažinti reguliariai atliekant baltųjų kraujo kūnelių skaičiaus tyrimus ir nutraukiant gydymą, jei tai yra būtina.
English: Skilarence can only be obtained with a prescription and it should be used under the supervision of a doctor who has experience in diagnosing and treating psoriasis.
Lithuanian: Skilarence galima įsigyti tik pateikus receptą ir jis turėtų būti vartojamas prižiūrint gydytojui, turinčiam psoriazės diagnozavimo ir gydymo patirties.
English: What are the risks associated with Skilarence?
Lithuanian: Kokia rizika siejama su Skilarence vartojimu?
English: It is thought to act on T cells (a type of white blood cell that forms part of the immune system) to prevent the cells from producing substances that cause inflammation and lead to psoriasis.
Lithuanian: Manoma, kad ji veikia T ląsteles (tam tikros rūšies baltuosius kraujo kūnelius, kurie yra imuninės sistemos dalis), neleisdama joms gaminti medžiagų, kurios sukelia uždegimą ir galiausiai psoriazę.
English: The most common side effects with Skilarence (which may affect more than 1 in 10 people) are effects on the digestive system (diarrhoea, bloating, belly ache and nausea), flushing (reddening of the skin) and low levels of lymphocytes (type of white blood cells) or of white blood cells in general.
Lithuanian: Dažniausi Skilarence šalutiniai reiškiniai (galintys pasireikšti daugiau kaip 1 žmogui iš 10) yra poveikis virškinimo sistemai (viduriavimas, pilvo pūtimas, pilvo skausmas ir pykinimas), raudonis (odos paraudimas) ir sumažėjęs limfocitų (tam tikros rūšies baltųjų kraujo kūnelių) arba apskritai baltųjų kraujo kūnelių skaičius.
English: A main study involving 704 patients with moderate to severe plaque psoriasis found that Skilarence was more effective than placebo (dummy treatment) at treating the disease and as effective as Fumaderm (a psoriasis medicine that contains dimethyl fumarate and monoethyl fumarate).
Lithuanian: Atlikus pagrindinį tyrimą su 704 vidutinio sunkumo arba sunkios formos plokšteline psoriaze sergančiais pacientais, nustatyta, kad Skilarence yra veiksmingesnis už placebą (preparatą be veikliosios medžiagos) gydant šią ligą ir toks pat veiksmingas kaip Fumaderm (vaistas nuo psoriazės, kurio sudėtyje yra dimetilfumarato ir monoetilfumarato).
English: After 16 weeks of treatment, 37% of patients taking Skilarence achieved this reduction, compared with 15% taking placebo and 40% taking Fumaderm .
Lithuanian: Po 16 gydymo savaičių tokius gydymo rezultatus pasiekė 37 proc. Skilarence vartojusių pacientų, 15 proc.
English: Skilarence must not be used in patients who have severe problems of the digestive system, liver or kidneys.
Lithuanian: Skilarence negalima vartoti pacientams, turintiems sunkių virškinimo sistemos, kepenų arba inkstų sutrikimų.
English: For the full list of all side effects reported with Skilarence, see the package leaflet.
Lithuanian: Išsamų visų šalutinių reiškinių, apie kuriuos pranešta gydant Skilarence, sąrašą galima rasti pakuotės lapelyje.
English: Skilarence contains the active substance dimethyl fumarate.
Lithuanian: Skilarence sudėtyje yra veikliosios medžiagos dimetilfumarato.
English: For more information about treatment with Skilarence, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Lithuanian: Daugiau informacijos apie gydymą Skilarence rasite pakuotės lapelyje (taip pat EPAR dalis) arba teiraukitės savo gydytojo ar vaistininko.
English: Psoriasis results from over-activity of the body's immune (defence) system.
Lithuanian: Psoriaze susergama, kai pernelyg suaktyvėja organizmo imuninė (apsaugos) sistema.
English: For practical information about using Skilarence, patients should read the package leaflet or contact their doctor or pharmacist.
Lithuanian: Praktinės informacijos apie Skilarence vartojimą pacientai turėtų ieškoti pakuotės lapelyje arba kreiptis į savo gydytoją ar vaistininką.
English: It is used in patients with moderate or severe disease for whom treatments applied direct to the skin do not work well enough.
Lithuanian: Vaistas skiriamas vidutinio sunkumo arba sunkios formos liga sergantiems pacientams, kuriems tiesiai ant odos vartojami vaistai nepakankamai veiksmingi.
English: The active substance in Skilarence, dimethyl fumarate, reduces the activity of the immune system.
Lithuanian: Veiklioji Skilarence medžiaga dimetilfumaratas slopina imuninę sistemą.
English: It must also not be used by women during pregnancy or if breast-feeding.
Lithuanian: Vaisto negalima vartoti moterims nėštumo laikotarpiu ir žindant.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Skilarence have also been included in the summary of product characteristics and the package leaflet.
Lithuanian: Į preparato charakteristikų santrauką ir pakuotės lapelį įtrauktos saugaus ir veiksmingo Skilarence vartojimo rekomendacijos ir atsargumo priemonės, kurių turi imtis sveikatos priežiūros specialistai ir pacientai.
English: How is Skilarence used?
Lithuanian: Kaip vartoti Skilarence?
English: Skilarence is a medicine used to treat plaque psoriasis, a disease that causes thickened, red and inflamed areas of skin with scaly patches.
Lithuanian: Skilarence - tai vaistas, kuriuo gydoma plokštelinė psoriazė - liga, kuria sergant ant odos formuojasi uždegiminiai sustorėjusios ir paraudusios odos plotai su pleiskanojančiomis dėmėmis.
English: It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use.
Lithuanian: Šis dokumentas yra Skilarence Europos viešo vertinimo protokolo (EPAR) santrauka. Jame paaiškinama, kaip agentūra vertino vaistą, kad galėtų rekomenduoti leisti prekiauti šiuo vaistu ES ir nustatytų jo vartojimo sąlygas.
English: The doctor may reduce the dose when the psoriasis has been brought under control.
Lithuanian: Suvaldžius psoriazę, gydytojas gali sumažinti vaisto dozę.
English: How does Skilarence work?
Lithuanian: Kaip veikia Skilarence?
English: Str. Cuza-Vodă, nr.
Lithuanian: Cuza-Vodã, nr.
English: Teva Pharmaceuticals Bulgaria EOOD Gogol 15
Lithuanian: Teva Pharmaceuticals Bulgarija EOOD Gogol 15
English: PARANOVA Rajatorpantie 41 C 01640 Vantaa Finland
Lithuanian: Paranova Oy Rajatorpantie 41 C 01640 Vantaa Finland
English: 08184 Palau-Solitá i Plegamans Barcelona
Lithuanian: 08184 Palau-Solitá i Plegamans
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states for Combined hormonal contraceptives
Lithuanian: VAISTŲ PAVADINIMŲ, FARMACINIŲ FORMŲ, STIPRUMO, VARTOJIMO BŪDŲ, RINKODAROS TEISĖS TURĖTOJŲ VALSTYBĖSE NARĖSE SĄRAŠAS
English: Graniczna 35
Lithuanian: ul.Graniczna 35
English: Str. Livezeni nr. 7A, 540472 Târgu Mureş, România.
Lithuanian: Livezeni nr. 7A, 540472 Târgu Mureº, Romania.
English: Rivium Westlaan 142 2909 LD Capelle a/d IJssel
Lithuanian: Rivium Westlaan 142 2909 LD Capelle a/d IJssel The Netherlands
English: Aktiengesellschaft Industriestr.
Lithuanian: Hexal Aktiengesellschaft Industriestr.
English: Frederic Mompou, 5 08960 Sant Just Desvern
Lithuanian: Frederic Mompou, 5 08960 Sant Just Desvern Barcelona
English: U kabelovny 130 102 37 Praha 10 Dolní Měcholupy Czech Republic
Lithuanian: U kabelovny 130 102 37 Praha 10 Dolní Mìcholupy Czech Republic
English: Empreendimento Lagoas Park, Edifício 7 - 3º Piso - Porto Salvo
Lithuanian: Empreendimento Lagoas Park, Edifício 7 - 3º PisoPorto Salvo
English: STRAGEN France SAS 52 rue de la République 69002 Lyon France
Lithuanian: STRAGEN France SAS 52 rue de la République 69002 Lyon
English: Żwirki i Wigury 81 02-091 Warszawa Poland
Lithuanian: ¯wirki i Wigury 81 02-091 Warszawa Poland
English: 1 28700 San Sebastián de los ReyesMadrid
Lithuanian: 1 28700 San Sebastián de los Reyes
English: Cambridge Science Park,
Lithuanian: Cambridge Science Park, Milton Road,
English: Karadžičova 12
Lithuanian: o. Karadžièova 12
English: Marszałka J.
Lithuanian: Marsza³ka J.
English: 06796 Brehna
Lithuanian: 06796 Brehna Germany
English: 9 Riverwalk National Digital Park Citywest Business Campus
Lithuanian: National Digital Park Citywest Business Campus Dublin 24
English: Teva The Netherlands B.V.
Lithuanian: Teva Nederland B.
English: Šmartinska cesta 53 1000 Ljubljana Slovenija
Lithuanian: Šmartinska cesta 53 1000 Ljubljana Slovenia
English: Teva Danmark A/S, Parallelvej 10-12, DK-2800 Kongens Lyngby,
Lithuanian: Teva Danmark A/S, Parallelvej 10-12, DK-2800 Kongens Lyngby, Denmark
English: Alameda da Beloura Edificio 1, 2º Escritorio 15
Lithuanian: Alameda da Beloura Edificio 1, 2º
English: MSD Sharp & Dohme Gesellschaft mit beschränkter Haftung Lindenplatz 1
Lithuanian: MSD Sharp & Dohme Gesellschaft mit beschränkter Haftung
English: Belgium EFFIK BENELUX Lenniksebaan 451
Lithuanian: Liuksemburgas EFFIK BENELUX Lenniksebaan 451
English: Nagano III, U
Lithuanian: Nagano III,
English: Radlická 3185/1c
Lithuanian: Radlická 3185/1c 150 00 Praha 5
English: 1800 Vilvoorde
Lithuanian: 1800 Vilvoorde Belgium
English: Merck Sharp and Dohme de España, S.A Josefa Valcárcel, 38 28027 Madrid Spain
Lithuanian: Merck Sharp and Dohme de España, S.A c/ Josefa Valcárcel, 38 28027 Madrid
English: Otto-Schott-Straße 15 07745 Jena Deutschland
Lithuanian: KG Otto-Schott-Straße 15 07745 Jena
English: Pelplińska 19 83-200 Starogard Gdański
Lithuanian: 83-200 Starogard Gdañski Poland
English: 1000 Ľubľana Slovenia
Lithuanian: 1000 ¼ub¾ana Slovenia
English: BAYER HELLAS AG Sorou 18-20
Lithuanian: BAYER HELLAS AG Sorou street 18-20 Maroussi
English: 05-340 Kołbiel, Poland
Lithuanian: 05-340 Ko³biel, Poland
English: Bayer d.o.o., Bravničarjeva 13, Ljubljana, Slovenia
Lithuanian: , Bravnièarjeva 13, Ljubljana, Slovenia
English: FAES FARMA, S.A. Maximo Aguirre, 14.
Lithuanian: Maximo Aguirre, 14.
English: WYETH MEDICA IRELAND Newbridge Ireland
Lithuanian: WYETH MEDICA AIRIJA Little Connell Newbridge
English: Berlipharm B.V.
Lithuanian: Berlipharm B.
English: Bayer Sante 220 avenue de la Recherche 59120 Loos France
Lithuanian: 220 avenue de la Recherche 59120 Loos
English: 48170 Zamudio Vizcaya
Lithuanian: 48170 Zamudio (Vizcaya) Spain
English: "ARAC" At Regulatory Affairs Consulting GmbH
Lithuanian: "ARAC" At Regulatory Affairs Consulting GmbH Kichengasse 48/3
English: Luxembourg Madaus GmbH Colonia Allee 15
Lithuanian: Liuksemburgas Madaus GmbH Colonia Allee 15
English: Luxembourg Ratiopharm GmbH Graf-Arco-Strasse 3
Lithuanian: Liuksemburgas Ratiopharm GmbH Graf-Arco-Strasse 3
English: WYETH FARMA, S.A. Ctra.
Lithuanian: WYETH FARMA, S.A.
English: Jenapharm GmbH & Co. KG
Lithuanian: Jenapharm GmbH & Co.
English: 1541 KA Koog aan de Zaan,
Lithuanian: 1541 KA Koog aan de Zaan, The Netherlands
English: Luxembourg BAYER N.V. J.E.
Lithuanian: Liuksemburgas BAYER SA-NV J.E.
English: Slovak Republic VIVAX EuroAsia s.r.o.
Lithuanian: VIVAX EuroAsia s.r.o.
English: Janssen-Cilag GmbH Johnson & Johnson Platz 1
Lithuanian: Janssen-Cilag GmbH Johnson & Johnson Platz 1 41470 Neuss
English: Morningside Healthcare Limited, 115 Narborough Road, Leicester LE3 0PA United Kingdom
Lithuanian: 115 Narborough Road, Leicester LE3 0PA United Kingdom
English: 92787 ISSY LES MOULINEAUX cedex 9 FRANCE
Lithuanian: 92787 Issy-les-Moulineaux cedex 9
English: 540306 Târgu Mureş România
Lithuanian: 99-105 540306 Târgu Mureº Romania
English: HU-1103 Budapest
Lithuanian: HU-1103 Budapest Hungary
English: Luxembourg Teva Pharma Belgium N.V.
Lithuanian: Liuksemburgas Teva Pharma Belgija N.
English: La Vallina s/n,
Lithuanian: C/ La Vallina s/n, Pol.
English: Geležinio Vilko g. 18A LT-08104 Vilnius Lithuania
Lithuanian: 18A LT-08104 Vilnius Lithuania
English: Rua Consiglieri Pedroso, 123Queluz de Baixo 2730-056 Barcarena Portugal
Lithuanian: Rua Consiglieri Pedroso, 123 2730-056 Barcarena Portugal
English: Chlormadinone acetate
Lithuanian: Chlormadinonas acetate
English: CT 13 9NJ
Lithuanian: Kent CT13 9NJ United Kingdom
English: Gyömrői út 19-21 HU-1103 Budapest Hungary
Lithuanian: Gyömrõi ut 19-21, H-1103 Budapest, Hungary
English: 2730-056 Barcarena Portugal
Lithuanian: Queluz de Baixo 2730-056 Barcarena Portugal
English: Pfizer Healthcare Ireland
Lithuanian: Pfizer Healthcare Ireland 9 Riverwalk
English: Farmaceuticos, Lda Edifício Cyprium, Av. 25 de Abril, 15, 2º F 2795-195 Linda-aVelha
Lithuanian: 25 de Abril, 15, 2º F 2795-195 Linda-a-Velha Portugal
English: Poligono Industrial Navatejera, La Vallina s/n, 24008 Villaquilambre, Leon
Lithuanian: La Vallina s/n, 24008 Villaquilambre,Leon Spain
English: Slovak Republic LADEEPHARMA Slovakia s.r.o.
Lithuanian: LADEEPHARMA Slovakia s.r.o.
English: Janssen-Cilag A/S, Postbox 149, Hammerbakken 19, DK-3460 Birkerød, Denmark
Lithuanian: Janssen-Cilag A/S, Hammerbakken 19 DK-3460 Birkerød Denmark
English: Pabianickie Zakłady Farmaceutyczne Polfa S.A. ul.
Lithuanian: Pabianickie Zak³ady Farmaceutyczne Polfa S.A.
English: 12277 Berlin Germany
Lithuanian: 12277 Berlin
English: Czech Republic Janssen-Cilag s.r.o.
Lithuanian: Janssen-Cilag s.r.o.
English: Calle La Vallina S/N Poligono Industrial Navatejera
Lithuanian: Laboratorios Leon Farma SA Calle La Vallina S/N Poligono Industrial Navatejera
English: LadeePharma LTD. Lajos street 48-66 E Budapest 1036
Lithuanian: LadeePharma Kft Lajos utca 48-66 H-1036 Budapest Hungary
English: 2770-192 Paço d' Arcos
Lithuanian: Edificio Vasco da Gama 2770-192 Paço d' Arcos Portugal
English: RANBAXY PHARMACIE GENERIQUES 11-15 Quai Dion Bouton
Lithuanian: RANBAXY PHARMACIE GENERIQUES 11-15 Quai Dion Bouton 92816 Puteaux Cedex France
English: Yarina 3000/30 micrograms film-coated tablets
Lithuanian: Yarina 3000/30 micrograms Filmcoated tablet
English: Slovak Republic Bayer, spol.
Lithuanian: Bayer, spol.
English: 2740-271 Porto Salvo Portugal
Lithuanian: Lagoas Park, Edificio 10 2740-271 Porto Salvo Portugal
English: DORINELLETEVA CONTINU 0.02 mg 3.00 mg
Lithuanian: DORINELLETEVA 0.02 mg 3.00 mg
English: Vaginal ring
Lithuanian: Stunden - Vaginalring
English: Zentiva Pharma GmbH Industriepark Frankfurt-Höchst, Gebäude K703
Lithuanian: Zentiva Pharma GmbH Industriepark FrankfurtHöchst, Gebäude K703 65926 Frankfurt am Main Germany
English: Jeanine 2000/30 micrograms film-coated tablets
Lithuanian: Jeanine 2000/30 micrograms Filmcoated tablet
English: Janssen-Cilag Limited 50-100 Holmers Farm Way
Lithuanian: Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
English: Rua Quinta Pinheiro, 5, Outurela 2794-003 Carnaxide Portugal
Lithuanian: Rua Quinta Pinheiro, 5 2794-003 Carnaxide Portugal
English: Czech Republic WH-Pharma s.r.o.
Lithuanian: WH-Pharma s.r.o.
English: Farmaceutiche Via Alcide De Gasperi, 165 B
Lithuanian: Farmitalia Industrie Chimico Farmaceutiche Via Alcide De Gasperi, 165 B 95127 Catania Italy
English: Belgium Teva Pharma Belgium N.V.
Lithuanian: Teva Pharma Belgium N.